NCT07277777 2026-01-06
125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors
Jinan Military General Hospital
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT04681131 2025-09-25
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
BioAtla, Inc.
Phase 2 Completed
NCT07142200 2025-08-26
DECIDING
RenJi Hospital
Phase 2 Not yet recruiting
NCT04673942 2024-10-26
BETA-PRIME
EpicentRx, Inc.
Phase 2 Recruiting
NCT06047860 2023-09-21
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05790447 2023-03-30
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Unknown